معرفی
Dr. Stephen Patterson is a Team Leader in Biological Chemistry and Drug Discovery, focusing on drug development for parasitic diseases such as visceral leishmaniasis and human African trypanosomiasis. His research integrates molecular biology, pharmacology, and chemical biology to identify novel drug targets and therapies. Key areas include antimalarial agents targeting Plasmodium falciparum cytochrome b, resistance profiling in Plasmodium through ResMAP technology, and development of diaminothiazole series for African trypanosomiasis.
- Research Interests: Molecular targets in parasites, antileishmanial agents, drug resistance mechanisms, and neglected tropical diseases.
His recent work highlights advancements in understanding drug action mechanisms via chemical pulldown mass spectrometry and saturation mutagenesis platforms. Collaborations span global health initiatives, emphasizing sustainable development goals for poverty reduction and health equity.
